Regen Gait Therapy Robot Usability Study, Apr 23, 2026
Summary
Clinical trial NCT07547683 registered on ClinicalTrials.gov (NIH) for the Regen gait therapy robot, a robot-assisted rehabilitation device designed to replicate therapist movements and provide assistance during treadmill walking. The study will enroll healthy adult participants to evaluate safety, feasibility, usability, and the device's ability to replicate therapist movement patterns. This registry entry documents the study parameters for a device developed by Regen Rehabilitation.
“This study aims to assess the safety, feasibility, usability, and ability to Regen to replicate the movement pattern of therapist in young healthy adults during treadmill walking.”
About this source
ClinicalTrials.gov is the NIH-run registry of every clinical trial conducted in the United States, plus most international trials sponsored by US-based companies or institutions. By federal law, sponsors must register Phase 2 through Phase 4 studies before enrolling patients and post results within a year of completion. This feed tracks every new trial registration and study update, around 700 a month: drug interventions, device studies, behavioral protocols, observational research. Watch this if you scout drug candidates moving into mid or late-stage development, monitor competitor pipelines, or follow rare disease research where new trials signal patient hope. GovPing parses sponsor, phase, intervention, and target indication on each entry.
What changed
The Regen gait therapy robot usability study has been registered on ClinicalTrials.gov (NCT07547683). This registry entry documents a prospective clinical investigation evaluating a robot-assisted rehabilitation device intended to replicate therapist movements and provide adaptive assistance during treadmill walking in healthy adults.
Sponsors and investigators developing similar robot-assisted therapy devices should note this trial as an indicator of the regulatory pathway being pursued for rehabilitation robotics. Healthcare providers and clinical researchers interested in robot-assisted gait therapy may find this registry useful for understanding study design parameters and outcome measures for similar devices entering clinical evaluation.
Archived snapshot
Apr 24, 2026GovPing captured this document from the original source. If the source has since changed or been removed, this is the text as it existed at that time.
Usability of the Regen Gait Therapy Robot in Healthy Adults
N/A NCT07547683 Kind: NA Apr 23, 2026
Abstract
Regen is a robot-assisted device designed to help therapists and improve the quality of treatment. It works by replicating the movement of the therapist and providing assistance as needed for the patient. This study aims to assess the safety, feasibility, usability, and ability to Regen to replicate the movement pattern of therapist in young healthy adults during treadmill walking.
Conditions: Healthy Adult Participants
Interventions: Regen Rehabilitation Assistive Device
Related changes
Get daily alerts for ClinicalTrials.gov Studies
Daily digest delivered to your inbox.
Free. Unsubscribe anytime.
Source
About this page
Every important government, regulator, and court update from around the world. One place. Real-time. Free. Our mission
Source document text, dates, docket IDs, and authority are extracted directly from NIH.
The summary, classification, recommended actions, deadlines, and penalty information are AI-generated from the original text and may contain errors. Always verify against the source document.
Classification
Who this affects
Taxonomy
Browse Categories
Get alerts for this source
We'll email you when ClinicalTrials.gov Studies publishes new changes.
Subscribed!
Optional. Filters your digest to exactly the updates that matter to you.